About
Dr. Olson is a pediatric neuro-oncologist at Seattle Children’s Hospital, a Full Member of the Fred Hutchinson Cancer Research Center (FHCRC) and a Professor at the University of Washington's School of Medicine. His research focuses on development of effective therapeutics and diagnostics for cancer patients. The Tumor Paint™ technology originated in Dr. Olson's lab at FHCRC. His team has conducted research that led to five national clinical trials for children with brain tumors. He is also Founder and Chairman of Presage Biosciences, a company which is based on a technology platform developed in his lab for assessing tumor response to drugs. Dr. Olson trained at the University of Michigan School of Medicine and Department of Pharmacology.
Position in the VCSift Database
- • 2 investors at Fred Hutchinson are tracked.
- • 1 investors hold the Full Member role in VCSift. James Olson is one of them.
- • 164 investors are based in Washington, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Washington, US
Contact Information
Find more investors like James
Search Investors